Screening options for prevention of congenital cytomegalovirus infection

Journal of Medical Screening

Volumn 8, Issue 3, 2001, Pages 119-124

  Peckham, C ^a   Tookey, P ^a   Logan, S ^a   Giaquinto, C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; VIRUS DNA;

CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; HUMAN; ITALY; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL SCREENING; REVIEW; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM; VIRUS CULTURE; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MASS SCREENING; NEONATAL SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS;

EID: 0034815692     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.8.3.119     Document Type: Review

References (52)

1. Cytomegalovirus infection in women attending a sexually transmitted disease clinic
2. Cytomegalovirus screened blood for neonatal intensive care units
3. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients
4. Maternal cytomegalovirus excretion and perinatal infection
5. Early acquisition of cytomegalovirus infection
6. Cytomegalovirus infection in day nurseries
7. Day-care centers and the spread of cytomegalovirus and parvovirus B19
8. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy
9. A prospective study of congenital cytomegalovirus infection in Japan
10. Report on a long term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature
11. Neonatal screening for congenital cytomegalovirus infections
12. L'infezione congenita da CMV: Studio propettico
13. Congenital cytomegalovirus infection: Predisposing maternal factors
14. Congenital cytomegalovirus infection in an urban Canadian community
15. Inapparent congenital cytomegalovirus infection. Clinical and epidemiologic characteristics in early infancy
16. Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants
17. Comparative study of diagnostic procedures for congenital cytomegalovirus infection
18. Congenital cytomegalovirus infection: Occurrence in an immune population
19. Congenital cytomegalovirus infection; the relative importance of primary and recurrent infection
20. A prospective study of primary cytomegalovirus infection during pregnancy: Final report
21. Primary CMV infection in pregnancy: Incidence, transmission to fetus, and clinical outcome
22. Maternal cytomegalovirus infection and perinatal transmission
23. The outcome on congenital cytomegalovirus infection in relation to maternal antibody status
24. A prospective study on congenital and acquired cytomegalovirus infections in infants
25. The outcome in children with congenital cytomegalovirus infection
26. Cytomegalovirus infection in pregnancy: Preliminary findings from a prospective study
27. Outcome of confirmed symptomatic congenital CMV infection
28. Outcome of symptomatic congenital CMV infection: Results of long term longitudinal follow up
29. Progressive hearing loss in infants with asymptomatic congenital CMV infection
30. Progressive and fluctuating sensorineural hearing loss in children w/th asymptomatic congenital cytomegalovirus infection
31. Neurodevelopmental assessment after congenital CMV infection
32. Intellectual development in school-aged children with asymptomatic congenital CMV infection
33. Secondary maternal CMV infection causing symptomatic congenital infection
34. Cytomegalic inclusion disease after recurrent materal infection
35. Symptomatic congenital CMV infection after maternal recurrent infection
36. Symptomatic congenital cytomegalovirus infection in infants born to mothers with pre-existing immunity to cytomegalovirus
37. PCR detection of cytomegalovirus DNA in serum as a diagnostic test for congenital cytomegalovirus infection
38. Cytomegalovirus DNA detection on Guthrie cards in patients with neonatal cholestasis
39. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase 2 study
40. Ganciclovir (GCV) treatment of symptomatic congenital cytomegalovirus (CMV) infections: Results of a phase III randomized trial
41. Vaccination against cytomegalovirus, the changeling demon
42. Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction leading to congenital infection
43. Prenatal diagnosis of fetal primary cytomegalovirus infection
44. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection
45. Infection with CMV during pregnancy: Specific IgM antibodies as a marker of recent primary infection
46. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection
47. Prenatal indicators of congenital cytomegalovirus infection
48. Summary of a workshop on surveillance for congenital cytomegalovirus disease
49. Should we routinely screen for cytomegalovirus antibody during pregnancy?
50. Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?